Histopathology and Tissue Shared Resource

HTSR Home | Services & Fees | Educational Resources | Publications | Schedule


2003 2004 2005 2006 2007 2008 2009 2010 2011


Cohen, A. W., D. S. Park, S. E. Woodman, T. M. Williams, M. Chandra, J. Shirani, A. Pereira de Souza, R. N. Kitsis, R. G. Russell, L. M. Weiss, B. Tang, L. A. Jelicks, S. M. Factor, V. Shtutin, H. B. Tanowitz, and M. P. Lisanti. (2003). Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts. Am.J.Physiol.Cell Physiol. 284:C457-474.

D'Amico, M., K. Wu, D. Di Vizio, A. T. Reutens, M. Stahl, M. Fu, C. Albanese, R. G. Russell, W. J. Muller, M. White, A. Negassa, H. W. Lee, R. A. DePinho, and R. G. Pestell. (2003). The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis. Cancer Res 63:3395-3402.

Han, Z., R. S. Slack, W. Li, and V. Papadopoulos. (2003). Expression of peripheral benzodiazepine receptor (PBR) in human tumors: relationship to breast, colorectal, and prostate tumor progression. J.Recept.Signal.Transduct.Res. 23:225-238.

Hsu, T., S. M. Hingley-Wilson, B. Chen, M. Chen, A. Z. Dai, P. M. Morin, C. B. Marks, J. Padiyar, C. Goulding, M. Gingery, D. Eisenberg, R. G. Russell, S. C. Derrick, F. M. Collins, S. L. Morris, C. H. King, and W. R. Jacobs, Jr. (2003). The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue. Proc.Natl Acad.Sci U.S.A 100:12420-12425.

Johnson, M., N. Kenney, A. Stoica, L. Hilakivi-Clarke, B. Singh, G. Chepko, R. Clarke, P. F. Sholler, A. A. Lirio, C. Foss, R. Reiter, B. Trock, S. Paik, and M. B. Martin. (2003). Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland. Nat.Med.9(8):1081-1084.

Nalbandian, A., L. Dettin, M. Dym, and N. Ravindranath. (2003). Expression of vascular endothelial growth factor receptors during male germ cell differentiation in the mouse. Biol.Reprod. 69:985-994.

Pengetnz, Y., M. S. Steed, K. R. Roby, P. F. Terranova, and C. C. Taylor. (2003). Src tyrosine kinase promotes survival and resistance to chemotheraputics in a mouse ovarian cancer cell line. Biochem.Biophys.Res.Commun. 309:377-383.

Wei, K., A. B. Clark, E. Wong, M. F. Kane, D. J. Mazur, T. Parris, N. K. Kolas, R. Russell, H. Hou, Jr., B. Kneitz, G. Yang, T. A. Kunkel, R. D. Kolodner, P. E. Cohen, and W. Edelmann. (2003). Inactivation of Exonuclease 1 in mice results in DNA mismatch repair defects, increased cancer susceptibility, and male and female sterility. Genes Dev. 17:603-614.

Wu, K., Y. Yang, C. Wang, M. A. Davoli, M. D'Amico, A. Li, K. Cveklova, Z. Kozmik, M. P. Lisanti, R. G. Russell, A. Cvekl, and R. G. Pestell. (2003). DACH1 inhibits TGF-beta signaling through binding Smad4. J.Biol.Chem. 278:51673-51684.

Oberst MD, Singh B, Ozdemirli M, Dickson RB, Johnson MD, Lin CY. (2003) Characterization of matriptase expression in normal human tissues. J Histochem Cytochem 51(8):1017-1025.

Cullen KJ, Newkirk KA, Schumaker LM, Aldosari N, Rone JD, Haddad BR. (2003) Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors. Cancer Res 63(23):8097-8102.

Tilli MT, Hudgins SL, Frech MS, Halama ED, Renou JP, Furth PA. (2003) Loss of protein phosphatase 2A expression correlates with phosphorylation of DP-1 and reversal of dysplasia through differentiation in a conditional mouse model of cancer progression. Cancer Res 63(22):7668-7673.

Liao DJ, Dickson RB. (2003) Cell death in MMTV-c-myc transgenic mouse mammary tumors may not be typical apoptosis. Lab Invest 83(10):1437-1449.

Cavalli LR, Urban CA, Dai D, de Assis S, Tavares DC, Rone JD, Bleggi-Torres LF, Lima RS, Cavalli IJ, Issa JP, Haddad BR. (2003) Genetic and epigenetic alterations in sentinel lymph nodes metastatic lesions compared to their corresponding primary breast tumors. Cancer Genet Cytogenet 2003; 146(1):33-40.

Wang C, Pattabiraman N, Zhou JN, Fu M, Sakamaki T, Albanese C, Li Z, Wu K, Hulit J, Neumeister P, Novikoff PM, Brownlee M, Scherer PE, Jones JG, Whitney KD, Donehower LA, Harris EL, Rohan T, Johns DC, Pestell RG. (2003) Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation. Mol Cell Biol 23(17):6159-6173.

Kang JY, Dolled-Filhart M, Ocal IT, Singh B, Lin CY, Dickson RB, Rimm DL, Camp RL. (2003) Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer. Cancer Res 63(5):1101-1105.

Jamerson MH, Johnson MD, Furth PA, Dickson RB. (2003) Early parity significantly elevates mammary tumor incidence in MMTV-c-myc transgenic mice. Transgenic Res 12(6):747-750.

Martin MB, Reiter R, Pham T, Avellanet YR, Camara J, Lahm M, Pentecost E, Pratap K, Gilmore BA, Divekar S, Dagata RS, Bull JL, Stoica A. (2003) Estrogen-like activity of metals in MCF-7 breast cancer cells. Endocrinology 144(6):2425-2436.

Li M, Ren S, Tilli MT, Flaws JA, Lubet R, Grubbs CJ, Furth PA. (2003) Chemoprevention of mammary carcinogenesis in a transgenic mouse model by alpha-difluoromethylornithine (DFMO) in the diet is associated with decreased cyclin D1 activity. Oncogene 22(17):2568-2572.

Cavalli, L. R., Singh, B., Isaacs, C., Dickson, R. B., and Haddad, B. (2004). Loss of Heterozygosity in normal breast tissues and benign breast legions from BRCA1/2 carriers patients with breast cancer. Cancer Genetics and Cytogenetics 149(1):38-43.

Combs, T. P., U. B. Pajvani, A. H. Berg, Y. Lin, L. A. Jelicks, M. Laplante, A. R. Nawrocki, M. W. Rajala, A. F. Parlow, L. Cheeseboro, Y. Y. Ding, R. G. Russell, D. Lindemann, A. Hartley, G. R. Baker, S. Obici, Y. Deshaies, M. Ludgate, L. Rossetti, and P. E. Scherer. (2004). A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology 145:367-383.

D'Amico, M., K. Wu, M. Fu, M. Rao, C. Albanese, R. G. Russell, H. Lian, D. Bregman, M. A. White, and R. G. Pestell. (2004). The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements. Cancer Res 64:4122-4130.

Hulit J, Wang C, Li Z, Albanese C, Rao M, Di Vizio D, Shah S, Byers SW, Mahmood R, Augenlicht LH, Russell R, Pestell RG. (2004). Cyclin D1 genetic heterozygosity regulates intestinal and colonic tumor number in Apcmin. Mol.Cell Biol. 24(17):7598-7611.

Isaacs, C., L. R. Cavalli, Y. Cohen, M. Pennanen, L. K. Shankar, M. Freedman, B. Singh, M. Liu, A. Gallagher, J. D. Rone, R. B. Dickson, D. Sidransky, and B. R. Haddad. (2004). Detection of LOH and mitochondrial DNA alterations in ductal lavage and nipple aspirate fluids from hngh-risk patients. Breast Cancer Res Treat 84:99-105.

Russell, R. G., A. Lasorella, L. E. Dettin, and A. Iavarone. (2004). Id2 drives differentiation and suppresses tumor formation in the intestinal epithelium. Cancer Res 64:7220-7225.

Woodman, S. E., M. W. Cheung, M. Tarr, A. C. North, W. Schubert, G. Lagaud, C. B. Marks, R. G. Russell, G. S. Hassan, S. M. Factor, G. J. Christ, and M. P. Lisanti. (2004). Urogenital alterations in aged male caveolin-1 knockout mice. J Urol. 171:950-957.

Jamerson MH, Johnson MD, Korsmeyer SJ, Furth PA, Dickson RB. (2004) Bax regulates c-Myc-induced mammary tumour apoptosis but not proliferation in MMTV-c-myc transgenic mice. Br J Cancer 91(7):1372-1379.

Pei XF, Noble MS, Davoli MA, Rosfjord E, Tilli MT, Furth PA, Russell R, Johnson MD, Dickson RB. (2004) Explant-cell culture of primary mammary tumors from MMTV-c-Myc transgenic mice. In Vitro Cell Dev Biol Anim 40(1-2):14-21.

Moroni M, Soldatenkov V, Zhang L, Zhang Y, Stoica G, Gehan E, Rashidi B, Singh B, Ozdemirli M, Mueller SC. (2004) Progressive loss of Syk and abnormal proliferation in breast cancer cells. Cancer Res 64(20):7346-7354.

Moroni M, Soldatenkov V, Zhang L, Zhang Y, Stoica G, Gehan E, Rashidi B, Singh B, Ozdemirli M, Mueller SC. (2004) Progressive loss of Syk and abnormal proliferation in breast cancer cells. Cancer Res 64(20):7346-7354.

Blancato J, Singh B, Liu A, Liao DJ, Dickson RB. (2004) Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses. Br J Cancer 90(8):1612-1619.

Henke RT, Haddad BR, Kim SE, Rone JD, Mani A, Jessup JM, Wellstein A, Maitra A, Riegel AT. (2004) Overexpression of the nuclear receptor coactivator AIB1 (SRC-3) during progression of pancreatic adenocarcinoma. Clin Cancer Res 10(18 Pt 1):6134-6142.

Moroni M, Soldatenkov V, Zhang L, Zhang Y, Stoica G, Gehan E, Rashidi B, Singh B, Ozdemirli M, Mueller SC. (2004) Progressive loss of Syk and abnormal proliferation in breast cancer cells. Cancer Res 64(20):7346-7354.

Santos SC, Cavalli LR, Cavalli IJ, Lima RS, Haddad BR, Ribeiro EM. (2004) Loss of heterozygosity of the BRCA1 and FHIT genes in patients with sporadic breast cancer from Southern Brazil. J Clin Pathol 57(4):374-377.

Stearns V, Gallagher A, Kleer CG, Singh B, Freedman M, Haddad BR, Isaacs C, Warren R, Brown M, Cullen J, Trock B, Hayes DF. (2004) A pilot study to establish a clinical model to perform phase II studies of breast cancer chemopreventive agents in women at high risk with biomarkers as surrogate endpoints for activity. Clin Cancer Res 10(24):8332-8340.

Moroni M, Soldatenkov V, Zhang L, Zhang Y, Stoica G, Gehan E, Rashidi B, Singh B, Ozdemirli M, Mueller SC. (2004) Progressive loss of Syk and abnormal proliferation in breast cancer cells. Cancer Res 64(20):7346-7354.

Siddiqui SF, Pawelek J, Handerson T, Lin CY, Dickson RB, Rimm DL, Camp RL. (2005) Coexpression of beta1,6-N-acetylglucosaminyltransferase V glycoprotein substrates defines aggressive breast cancers with poor outcome. Cancer Epidemiol Biomarkers Prev 14(11 Pt 1):2517-2523.

Asatiani, E., W. X. Huang, A. Wang, O. E. Rodriguez, L. R. Cavalli, B. R. Haddad, and E. P. Gelmann. (2005). Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer. Cancer Res. 65:1164.

Frech, M. S., E. D. Halama, M. T. Tilli, B. Singh, E. J. Gunther, L. A. Chodosh, J. A. Flaws, and P. A. Furth. (2005). Deregulated estrogen receptor alpha expression in mammary epithelial cells of transgenic mice results in the development of ductal carcinoma in situ. Cancer Res. 65:681-685.

Jones, L. P., M. Li, E. D. Halama, Y. Ma, R. Lubet, C. J. Grubbs, C. X. Deng, E. M. Rosen, and P. A. Furth. (2005). Promotion of mammary cancer development by tamoxifen in a mouse model of Brca1-mutation-related breast cancer. Oncogene 24:3554-3562.

Tilli, M. T., R. Reiter, A. S. Oh, R. T. Henke, K. McDonnell, G. I. Gallicano, P. A. Furth, and A. T. Riegel. (2005). Overexpression of an N-terminally truncated isoform of the nuclear receptor coactivator amplified in breast cancer 1 leads to altered proliferation of mammary epithelial cells in transgenic mice. Mol.Endocrinol. 19:644-656.

Uren A, Fallen S, Yuan H, Usubutun A, Kucukali T, Schlegel R, Toretsky JA. (2005). Activation of the canonical Wnt pathway during genital keratinocyte transformation: a model for cervical cancer progression. Cancer Research 65, 6199-6206.

Yin, Y., R. Bai, R. G. Russell, M. E. Beildeck, Z. Xie, L. Kopelovich, and R. I. Glazer. (2005). Characterization of medroxyprogesterone and DMBA-induced multilineage mammary tumors by gene expression profiling. Mol.Carcinog. 44: 42-50.

Yin, Y., R. G. Russell, L. E. Dettin, R. Bai, Z. L. Wei, A. P. Kozikowski, L. Kopleovich, and R. I. Glazer. (2005). Peroxisome proliferator-activated receptor delta and gamma agonists differentially alter tumor differentiation and progression during mammary carcinogenesis. Cancer Res. 65:3950-3957.

Chepko G, Slack R, Carbott D, Khan S, Steadman L, Dickson RB. (2005) Differential alteration of stem and other cell populations in ducts and lobules of TGFalpha and c-Myc transgenic mouse mammary epithelium. Tissue Cell 37(5):393-412.

Parrish A, Halama E, Tilli MT, Freedman M, Furth PA. (2005) Reflectance confocal microscopy for characterization of mammary ductal structures and development of neoplasia in genetically engineered mouse models of breast cancer. J Biomed Opt 10(5):051602.

Lee JW, Yong SS, Choi JJ, Lee SJ, Kim BG, Park CS, Lee JH, Lin CY, Dickson RB, Bae DS. Increased expression of matriptase is associated with histopathologic grades of cervical neoplasia. Hum Pathol 2005; 36(6):626-633.